News
-
-
-
PRESS RELEASE
HAMBORNER REIT AG: Stable business performance in the first half of the year in line with planning - confirmation of full-year forecast for 2024
HAMBORNER REIT AG reports stable business performance in the first half of 2024, with increased rental income and FFO. Full-year forecast for 2024 confirmed -
-
-
PRESS RELEASE
Communiqué : Le traitement d’induction par Sarclisa a démontré une amélioration significative de la survie sans progression chez les patients atteints d’un myélome multiple nouvellement diagnostiqué et éligibles à une transplantation
Le traitement d’induction par Sarclisa montre une amélioration significative de la survie sans progression chez les patients atteints de myélome multiple nouvellement diagnostiqués et éligibles à une transplantation -
PRESS RELEASE
Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
New data shows Sarclisa induction therapy improves progression-free survival in transplant-eligible newly diagnosed multiple myeloma patients. GMMG-HD7 study results are promising for Sarclisa as part of frontline treatment -
PRESS RELEASE
grenke increases Group earnings and improves cost-income ratio in the first half of 2024
grenke AG increases Group earnings by 11.3% and improves cost-income ratio to 57.1% in the first half of 2024. The company reconfirms its 2024 forecast, showcases refinancing strength, and reports positive financial figures -
-
PRESS RELEASE
Knorr-Bremse Aktiengesellschaft: Knorr-Bremse Maintains Profitable Growth
Knorr-Bremse AG maintains profitable growth with impressive 2024 first half results and increased full-year guidance. Continuity on the Executive Board confirmed. Details on BOOST 2026 strategy and divisional performances
